Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Curr Med Chem ; 2024 Feb 06.
Article in English | MEDLINE | ID: mdl-38321902

ABSTRACT

BACKGROUND: Iron chelators (ICs) have recently emerged as one of the new methods of treatment for viral infections. This study aimed to evaluate the efficiency and safety of natural ICs compared to synthetic ICs. Natural and synthetic ICs are the most common therapeutic agents tested for the treatment of viral infections. When evaluated against synthetic ICs, natural ICs are probably favored owing to their lower toxicity and safer properties. The main objective of the present systematic review was to assess the current evidence on the role of pharmacological mechanisms in the treatment of viral infections. METHOD: This study was designed as a systematic review in which search strategies were focused on two electronic databases, PubMed, and Scopus, between 2017 and 2021. A search filter with two subjects, "iron chelators" and "viral infection", was employed. RESULTS: According to the results, both natural and synthetic chelators had a considerable impact on the treatment of viral infections via various mechanisms, with natural ICs being the most extensively used. CONCLUSION: Natural and synthetic ICs exert their effects through different pharmacological mechanisms. Among these compounds, natural chelators are more widely used due to their safety, efficacy, and a wider range of applications.

2.
J Drug Target ; 31(9): 950-961, 2023 12.
Article in English | MEDLINE | ID: mdl-37842966

ABSTRACT

As bioactive molecules, peptides and proteins are essential in living organisms, including animals and humans. Defects in their function lead to various diseases in humans. Therefore, the use of proteins in treating multiple diseases, such as cancers and hepatitis, is increasing. There are different routes to administer proteins, which have limitations due to their large and hydrophilic structure. Another limitation is the presence of biological and lipophilic membranes that do not allow proteins to pass quickly. There are different strategies to increase the absorption of proteins from these biological membranes. One of these strategies is to use compounds as absorption enhancers. Absorption enhancers are compounds such as surfactants, phospholipids and cyclodextrins that increase protein passage through the biological membrane and their absorption by different mechanisms. This review focuses on using other absorption enhancers and their mechanism in protein administration routes.


Subject(s)
Peptides , Proteins , Animals , Humans , Phospholipids , Cell Membrane/metabolism , Drug Delivery Systems
3.
Ann Pharm Fr ; 81(6): 968-976, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37633459

ABSTRACT

Nanofibers are a class of nanomaterial with specific physicochemical properties and characteristics making them quite sought after and investigated by researchers. Lipopeptide biosurfactant (LPB) formulation properties were previously established in wound healing. LPB were isolated from in vitro culture of Acinetobacter junii B6 and loaded on nanofibers formulation produced by electrospinning method with different ratios of carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), and Poloxamer. Numerous experimental control tests were carried out on formulations, including physicochemical properties which were evaluated by using dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FT-IR), morphology study by scanning electron microscopy (SEM), and thermal stability. The best nanofibers formulation was obtained by the electrospinning method, with a voltage of 19.8 volts, a discharge capacity of 1cm/h, a cylindrical rotating velocity of 100rpm, and a needle interval of 7cm from the cylinder, which continued for 7hours. The formulation contained 2% (w/v) CMC, 10% (w/v) poloxamer, 9% (w/v) PVA, and 5% (w/v) LPB. This formula had desirable physicochemical properties including spreadability, stability, and uniformity with the particle size of about 590nm.

4.
3 Biotech ; 13(10): 321, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37649591

ABSTRACT

The Bacillus pumilus SG isolated from soil samples at the Persian Gulf was analyzed for its ability to produce biosurfactant. Various screening techniques were used for evaluating biosurfactant production and confirming biosurfactant presence in the culture supernatant. Most n-alkanes in the bacterial culture media were effectively degraded in the presence of biosurfactant acquired from the bacteria. The highest interfacial tension (IT) reduction (42 mN/m) was obtained at 24-h fermentation time (exponential phase) and did not change significantly afterwards. The glycolipid structure of the biosurfactant was revealed through NMR and FTIR spectroscopy analysis. Two-level factorial design was then applied for optimization of biosurfactant production, where a maximal reduction of culture broth IT (30 mN/m) acquired in the presence of crude oil (0.5%, v/v), NaNO3 (1 g/L), yeast extract (1 g/L), peptone (2 g/L) and temperature of 25 °C. The produced biosurfactant that exhibited a critical micelle concentration of 0.1 mg/ml was thermally stable. The glycolipid biosurfactant also displayed significant antibacterial activities against both Gram-positive and Gram-negative bacteria. The maximum inhibition of glycolipids biosurfactant was found against Acinetobacter strains (zone of inhibition, 45 mm). In addition, antibiofilm activities with a 50-90% biofilm reduction percent were indicated by the glycolipid biosurfactant. In conclusion, the glycolipid biosurfactant produced by B. pumilus SG revealed a wide range of functional properties and was verified as a good candidate for biomedical application. In conclusion, the glycolipid biosurfactant produced by B. pumilus SG showed a wide range of functional properties in this study, and in the case of further in vivo studies, it can be investigated a good candidate for biomedical applications such as use against biofilm or in pharmaceutical formulations.

5.
Wounds ; 35(5): E178-E185, 2023 05.
Article in English | MEDLINE | ID: mdl-37285589

ABSTRACT

INTRODUCTION: Recurrent aphthous stomatitis is a common lesion of the oral cavity, and many treatments have been introduced by researchers. OBJECTIVE: This study aims to determine the effect of biosurfactant lipopeptide (Acinetobacter baumannii and Pseudomonas aeruginosa) adhesive mucus paste on the healing process of oral wounds. MATERIALS AND METHODS: The studied population included 36 people (age range, 20-41 years). The volunteers had a history of oral ulcers and were randomly assigned to 3 groups: positive control (mouthwash chlorhexidine 0.2%), biosurfactant lipopeptide mucoadhesive (A baumannii and P aeruginosa), and base groups. In this analysis, the 2-paired sample t test, ANOVA, and Kruskal-Wallis test (Wilcoxon signed-rank test) were used. RESULTS: On the second day of treatment, the efficacy index of the positive control group was higher than that of the mucoadhesive and the base groups (P = .04) and there was a significant difference between the mucoadhesive group and the positive control group compared with the base group (P = .001). On the sixth day of treatment, the positive control group was significantly different from the mucoadhesive and base groups in terms of wound size (P < .05). CONCLUSIONS: This study showed that the use of mucoadhesive gel formation containing lipopeptide biosurfactant reduces pain and wound size compared to mucoadhesive without biosurfactant lipopeptide treatment, but it has less effect than routine treatment. Therefore, other studies should be done.


Subject(s)
Adhesives , Stomatitis, Aphthous , Humans , Young Adult , Adult , Adhesives/pharmacology , Lipopeptides/pharmacology , Lipopeptides/therapeutic use , Wound Healing
6.
Pharm Dev Technol ; 28(5): 492-500, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37129530

ABSTRACT

Temperature-sensitive drug delivery systems (TSDDS) are one of the systems that have received more attention in medical science these days due to their advantages. As these systems are sensitive to temperature, drug delivery to the target becomes more specific. Temperature-sensitive nanogels have many applications, including microbial infections, cancer therapy, transdermal use, and tissue repair. These systems are characterized by minimal toxicity, improved therapeutic efficacy, and reduced exposure to normal cells. This mini-review is prepared with different types of temperature-sensitive nanogel formation, release mechanisms, and their different applications. Various systems reported under these categories for targeted and controlled delivery of different classes of drugs, such as anti-cancer and antibiotic drugs with special emphasis on anti-cancer drugs and tissue healing, are discussed in this mini-review.


Subject(s)
Antineoplastic Agents , Neoplasms , Humans , Nanogels , Temperature , Drug Delivery Systems , Neoplasms/drug therapy , Drug Carriers
7.
J Wound Care ; 32(Sup4a): xxxix-xlvi, 2023 Apr 01.
Article in English | MEDLINE | ID: mdl-37029983

ABSTRACT

Wound healing refers to the complex process of restoring the forms and functions of damaged tissues. Multiple growth factors and released cytokines tightly regulate the wound site. Healing processes can be disrupted by any alteration that would aggravate the damage and lengthen the repair process. Some of the conditions that may impair wound healing include infections and inflammation. Surfactants are amphiphilic compounds widely used in various formulations including detergents, food, pharmaceuticals and cosmetics. Biosurfactants, therefore, are surface-active compounds produced by biological agents, particularly yeast or bacteria, and represent a safer and environmentally preferred alternative to chemical surfactants. Numerous studies have targeted surface-active molecules as wound healing agents for their anti-inflammatory, antioxidant and antibacterial potential. This review focuses on surface-active molecules used in wound healing activities and analyses their effectiveness and mechanisms of action.


Subject(s)
Inflammation , Surface-Active Agents , Humans , Surface-Active Agents/pharmacology , Surface-Active Agents/therapeutic use , Antioxidants , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Wound Healing/physiology
8.
Pharm Dev Technol ; 28(5): 383-402, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37086283

ABSTRACT

Exosomes are one type of extracellular vesicles with size ranging from 30 to 150 nm, which are involved in intercellular communication by transporting specific proteins, nucleic acids, and low molecular weight metabolites. The size and competence of exosomes to transfer biological materials to recipient cells have made them suitable for biomedical use. Therefore, exosomes have been studied as drug delivery systems for various diseases due to low immunogenicity, preferred tumor homing, innate and acquired targetability, and stability. They are secreted by almost all cells from multivesicular endosomes and retrieved in all body fluids including bile, saliva, blood, lymph, urine, cerebrospinal fluid, milk, and etc. Plants' organs also secrete exosomes (Plant-derived exosome-like nanoparticles (PELNs)) which have been considered as an economical and affordable source of production. PELNs are pharmacologically rich in active molecules because of owning unique compositional and morphological features and they can be used as natural nano-carrier for transporting exogenous molecules. In this review, the bio-component and the applications of PELNs as drug delivery systems in neural disorders, tumor-targeted delivery, and gene delivery have been reviewed in different plants such as aloe, turmeric, ginger, lemon, grapefruit, grape, and strawberry.


Subject(s)
Exosomes , Nanoparticles , Neoplasms , Humans , Exosomes/metabolism , Exosomes/pathology , Drug Delivery Systems , Neoplasms/drug therapy , Neoplasms/metabolism , Cell Communication , Nanoparticles/chemistry
9.
J Cosmet Dermatol ; 21(11): 6326-6335, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35876761

ABSTRACT

BACKGROUND: One of the dermatologic problems in elderly people is skin aging, which is a natural and complex biological process. Morin is a flavonoid with high radical scavenging activity as well as antityrosinase effects but its low water solubility has restricted its application. AIMS: This research aimed to develop, characterize, and optimize morin niosomes composed of non-ionic surfactants, and evaluate the in vitro UV protection and antiaging effectiveness. METHODS: Niosomes were prepared by the film hydration method with sorbitan monostearate (Span® 40), polyoxyethylenesorbitan monopalmitate (Tween® 40), and cholesterol. The niosomes were characterized in terms of size, zeta potential, morphology, in vitro release behavior, and drug entrapment efficiency (EE). Afterward, antiaging activity, including antityrosinase, antioxidant, intracellular reactive oxygen species (ROS) scavenging, and sun protection factor (SPF) were evaluated. RESULTS: The optimized niosomes appeared as unilamellar vesicles with a spherical shape, with size, zeta potential, and EE values of 6.13 ± 0.40 µm, -0.81 ± 0.32 mV, and 89.35% ± 2.80%, respectively. The noisome formulation remained stable at -4°C for 3 months. The release profiles of morin loaded in niosomes revealed the extended release over 8 h and followed zero-order release kinetics. Morin-loaded niosomes exhibited no significant toxicity toward the L929 cell line. The niosome loaded with morin showed anti skin aging activity, including antityrosinase effects (IC50 = 13.17 ± 1.58 µg/ml), antioxidant (IC50 = 28.49 ± 2.05 µg/ml), and ROS scavenging activity. For 1% and 5% (w/w) morin niosomes in eucerin base cream, the SPF was 39.03 ± 1.01 and 38.15 ± 0.82, respectively, whereas the noisome-free morin cream exhibited an SPF of 4.47 ± 0.56. CONCLUSION: Morin-loaded niosome has been shown to provide sun protection and antiaging effects, suggesting that it could be used in pharmaceutical and cosmetic products.


Subject(s)
Liposomes , Radiation Protection , Humans , Aged , Antioxidants/pharmacology , Antioxidants/metabolism , Reactive Oxygen Species , Flavonoids
10.
Appl Biochem Biotechnol ; 194(4): 1755-1774, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34982373

ABSTRACT

Biosurfactants are microbial-derived compounds with surface and emulsifying activities. Environmental and industrial applications make glycolipid biosurfactants particularly interesting among the several categories of biosurfactants. A potential glycolipid biosurfactant resource, Shewanella algae, was isolated from marine samples at the Persian Gulf. The glycolipid biosurfactant caused a reduction in water surface tension from 72 to 43 mN/m with a 0.25 mg/mL critical micelle concentration (CMC). Two-level factorial design was then applied for optimization of biosurfactant production, where a maximal reduction of culture broth surface tension (31 mN/m) acquired in the presence of crude oil (0.5%, v/v), NaNO3 (0.2 g/L), NH4Cl (0.7 g/L), and peptone (0.5 g/L). GC-MS analysis of the culture broth showed when crude oil was used as the sole carbon source, S. algae was able to degrade most of its alkane components. Nuclear magnetic resonance (NMR) and Fourier transform infrared (FTIR) spectroscopy revealed the glycolipid structure of biosurfactant. The glycolipid biosurfactant exhibited considerable growth inhibition of clinical bacterial pathogens and disrupted the preformed biofilms of Bacillus cereus (83%), Streptococcus pneumoniae (53%), Pseudomonas aeruginosa (92%), Escherichia coli (64%), Klebsiella pneumoniae (87%), and Acinetobacter sp. (72%). In conclusion, the glycolipid biosurfactant secreted by S. algae exhibited a wide range of functional properties and was evidenced as a promising candidate for biomedical application.


Subject(s)
Anti-Infective Agents , Petroleum , Shewanella , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Biofilms , Glycolipids/chemistry , Glycolipids/pharmacology , Shewanella/metabolism , Surface-Active Agents/chemistry
11.
Protein Pept Lett ; 28(11): 1230-1237, 2021.
Article in English | MEDLINE | ID: mdl-34303327

ABSTRACT

There are many proteins and enzymes in the human body, and their dysfunction can lead to the emergence of a disease. The use of proteins as a drug is common in various diseases such as diabetes. Proteins are hydrophilic molecules whose spatial structure is critical to their correct function. There are different ways for the administration of proteins. Protein structures are degraded by gastric acid and enzymes in the gastrointestinal tract and have a slight ability to permeate from the gastrointestinal epithelium due to their large hydrophilic nature. Therefore, their oral use has limitations. Since the oral route for the administration of drugs is one of the best and easiest routes for patients, many studies have been done to increase the stability, penetration, and ultimately, the bioavailability of proteins through oral administration. One of the studied strategies for oral delivery of protein is the use of pH-sensitive polymer-based carriers. These carriers use different pH-sensitive polymers, such as eudragit®, chitosan, dextran, and alginate. The use of pH-sensitive polymer- based carriers by protecting the protein from stomach acid (low pH) and degrading enzymes, increasing permeability and maintaining the spatial structure of the protein, leads to increased bioavailability. In this review, we focus on the various polymers used to prepare pH-sensitive polymer- based carriers for the oral delivery of proteins.


Subject(s)
Chitosan , Drug Carriers , Polymethacrylic Acids , Proteins , Administration, Oral , Chitosan/chemistry , Chitosan/therapeutic use , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/therapeutic use , Drug Carriers/chemistry , Drug Carriers/therapeutic use , Humans , Hydrogen-Ion Concentration , Polymethacrylic Acids/chemistry , Polymethacrylic Acids/therapeutic use , Proteins/chemistry , Proteins/therapeutic use
12.
Avicenna J Phytomed ; 11(4): 417-427, 2021.
Article in English | MEDLINE | ID: mdl-34290972

ABSTRACT

OBJECTIVE: Application of vesicular drug delivery systems has made major progress in pharmaceutical science and technology. Niosomal drug delivery is potentially efficient to improve the pharmacokinetic and pharmacological properties of many compounds. Curcumin (CUR) has several documented anticancer activities; however, it has a low bioavailability that necessitates the development of efficient delivery systems. Accordingly, different niosomal preparations were prepared and evaluated in the present study to find a suitable delivery system. MATERIALS AND METHODS: Span and Tween 20, 40, 60, and 80 were employed with various concentrations of cholesterol for studying the ability to form curcumin-loaded niosomes. Multiple characterization techniques including visual evaluation, particle size analysis, stability, encapsulation efficiency (EE), and release profile were studied. Cytotoxicity of curcumin niosomes on MCF-7 and 3T3 cell lines was determined using MTT assay. RESULTS: Visual and particle size analysis indicated the formation of seven niosomal formulations in the micron size range, while the formulation consisted of Tween 40/cholesterol (50/50 M%) with 0.05% w/v CUR had an average diameter of 475 nm. The latter formulation was selected and it had EE of 78.5%. The CUR release profile showed 18.7% release over a period of 300 min. The MTT results showed that CUR incorporation significantly increased the cytotoxicity of niosomes and the extent of toxicity was higher in MCF-7 cells. CONCLUSION: In this study, a simple niosomal formulation was developed for CUR loading with favorable physicochemical properties. The presented niosomal curcumin had also considerable effects in cell toxicity studies, which can be suggested for future anticancer studies.

13.
Drug Des Devel Ther ; 14: 541-550, 2020.
Article in English | MEDLINE | ID: mdl-32103896

ABSTRACT

BACKGROUND: Microemulsions drug delivery systems (MDDS) have been known to increase the bioavailability of hydrophobic drugs. The main challenge of the MDDS is the development of an effective and safe system for drug carriage and delivery. Biosurfactants are preferred surface-active molecules because of their lower toxicity and safe characteristics when compared to synthetic surfactants. Glycolipid and lipopeptide are the most common biosurfactants that were tested for MDDS. The main goal of the present systematic review was to estimate the available evidence on the role of biosurfactant in the development of MDDS. SEARCH STRATEGY: Literature searches involved the main scientific databases and were focused on the period from 2005 until 2017. The Search filter composed of two items: "Biosurfactant" and/or "Microemulsion." INCLUSION CRITERIA: Twenty-four studies evaluating the use of biosurfactant in MDDS were eligible for inclusion. Among these 14 were related to the use of glycolipid biosurfactants in the MDDS formulations, while four reported using lipopeptide biosurfactants and six other related review articles. RESULTS: According to the output study parameters, biosurfactants acted as active stabilizers, hydrophilic or hydrophobic linkers and safety carriers in MDDS, and among them glycolipid biosurfactants had the most application in MDDS formulations. CONCLUSION: Synthetic surfactants could be replaced by biosurfactants as an effective bio-source for MDDS due to their excellent self-assembling and emulsifying activity properties.


Subject(s)
Drug Delivery Systems , Pharmaceutical Preparations/administration & dosage , Surface-Active Agents/chemistry , Drug Carriers/chemistry , Emulsions , Glycolipids/chemistry , Humans , Hydrophobic and Hydrophilic Interactions , Lipopeptides/chemistry , Pharmaceutical Preparations/chemistry
14.
Microb Pathog ; 138: 103806, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31629797

ABSTRACT

Lipopeptide biosurfactants (LPBs) are amphiphilic compounds produced by microorganisms exhibiting various biological activities. The main aim of the present study was to assess the in vitro antimicrobial, anti-biofilm, and cytotoxic effects of LPB produced by Acinetobacter junii (AjL). We determined AjL minimum inhibitory concentration (MIC) against both Gram-positive and Gram-negative bacteria as well as two fungal strains. Also, the anti-biofilm activity of AjL against the biofilm produced by clinically isolated bacterial strains was investigated. The AjL non-selectively showed activity against both Gram-positive and Gram-negative bacterial strains. The obtained results of the present study exhibited that the AjL in concentrations nearly below critical micelle concentration (CMC) has an effective antibacterial activity. It was found that the MIC values of AjL were lower than standard antifungal and it exhibited nearly 100% inhibition against Candida utilis. The attained results of the biofilm formation revealed that AjL disrupted the biofilm of Proteus mirabilis, Staphylococcus aureus, and Pseudomonas aeruginosa at 1250 µg/ml and 2500 µg/ml concentrations. The attained results of cytotoxic effect (determined by WST-1 assay) of the AjL revealed IC50 of 7.8 ±â€¯0.4 mg/ml, 2.4 ±â€¯0.5 mg/ml, and 5.7 ±â€¯0.1 mg/ml, against U87, KB, and HUVEC cell lines, respectively. The results indicated that AjL has a potential application in the relatively new field of biomedicine.


Subject(s)
Acinetobacter/metabolism , Antimicrobial Cationic Peptides/biosynthesis , Lipopeptides/biosynthesis , Surface-Active Agents/metabolism , Bacteria/drug effects , Biofilms/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Fungi/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Microbial Sensitivity Tests , Staphylococcus aureus/drug effects
15.
Drug Des Devel Ther ; 13: 3405-3418, 2019.
Article in English | MEDLINE | ID: mdl-31579238

ABSTRACT

Peptides are the most abundant biological compounds in the cells that act as enzymes, hormones, structural element, and antibodies. Mostly, peptides have problems to move across the cells because of their size and poor cellular penetration. Therefore, a carrier that could transfer peptides into cells is ideal and would be effective for disease treatment. Until now, plenty of polymers, e.g., polysaccharides, polypeptides, and lipids were used in drug delivery. Hydrogels made from polysaccharides showed significant development in targeted delivery of peptide hormones because of their natural characteristics such as networks, pore sizes, sustainability, and response to external stimuli. The main aim of the present review was therefore, to gather the important usages of the hydrogels as a carrier in peptide hormone delivery and their application in tissue engineering and regenerative medicine.


Subject(s)
Drug Delivery Systems , Hydrogels/chemistry , Peptide Hormones/therapeutic use , Tissue Engineering , Drug Carriers/chemistry , Humans , Peptide Hormones/chemistry , Regenerative Medicine
16.
Int J Biol Macromol ; 112: 712-719, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29425877

ABSTRACT

In the present study the produced biosurfactant of Acinetobacter junii B6 (recently isolated from Iranian oil excavation site) were partially purified and identified by high performance thin layer chromatography (HPTLC), Fourier transform infrared spectroscopy (FTIR), and proton nuclear magnetic resonance (1H NMR). Elemental analysis of the biosurfactant by energy dispersive X-ray spectroscopy (EDS) revealed that the biosurfactant was anionic in nature. The physiochemical properties of the lipopeptide biosurfactant were evaluated by determination of its critical micelle concentration (CMC) and hydrophile-lipophile balance (HLB). The produced biosurfactant decreased the surface tension of water to 36mNm-1 with the CMC of approximately 300mg/l. Furthermore, the solubility properties of the biosurfactant (dissolved in phosphate-buffer saline solution, pH7.4) were investigated by turbidity examination, dynamic light scattering (DLS) measurements, and transmission electron microscopy (TEM) inspection. It could be concluded that the biosurfactant showed the spherical-shaped vesicles at a concentration higher than its CMC and the circular dichroism (CD) spectra showed that the secondary structure of the biosurfactant vesicles is dominated by the ß sheet.


Subject(s)
Acinetobacter/chemistry , Lipopeptides/chemistry , Lipopeptides/pharmacology , Protein Aggregates , Surface-Active Agents/chemistry , Surface-Active Agents/pharmacology , Chromatography, Thin Layer , Circular Dichroism , Erythrocytes/drug effects , Hemolysis/drug effects , Humans , Hydrophobic and Hydrophilic Interactions , Protein Aggregates/drug effects , Proton Magnetic Resonance Spectroscopy , Rheology , Spectrometry, X-Ray Emission , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Surface Tension , Temperature , Thermogravimetry
17.
Curr Pharm Biotechnol ; 18(11): 900-908, 2017.
Article in English | MEDLINE | ID: mdl-29173159

ABSTRACT

BACKGROUND: Recently, the development of a safe bioactive material with antioxidant properties, which can improve healing activity are focusing. Biosurfactants are very famous for their antimicrobial and free radical scavenging activities. Thereof, the main aim of the present study was to investigate the antioxidant and wound healing activity of the lipopeptide biosurfactant (LBS) produced by Acinetobacter junii B6. DPPH radical scavenging activities and FRAP assays were used to measure the antioxidant properties. METHODS: For evaluation of the wound healing activity, 36 rats (previously wounded in depilated thoracic region) were randomly distributed into six groups and chromatic, wound contraction, and histopathological feature were examined. The assessment levels of reactive oxygen species (ROS) after LBS exposure were determined using malondialdehyde (MDA), hydrogen peroxide (H2O2), and glutathione (GSH) assay kits. RESULTS: DPPH assay showed notable scavenging activities at the corresponding concentrations with IC50 value of 0.7 mg/ml. The reductive potency of the LBS showed lower performance at low concentration, while exhibited a remarkable increase at higher concentration. The best histopathological remission was achieved following treatment by 5 mg/ml of the LBS. Scar wounds at day 13 showed the lowest lesion sizes, increased re-epithelialization, hair follicle detection, and decreased amounts of neutrophilic inflammation, immaturity of the wound bed, erythema, edema, capillary, and retention of necrotic tissue. CONCLUSION: Results from MDA, H2O2, and GSH levels of the treated sample confirmed the scavenging property of the bacterial derived LBS through ROS. It could be concluded that the pharmaceutical formula encourages the wound healing because of its notable antioxidant capacity. HIGHLIGHTS: • DPPH and FRAP assays showed notable scavenging activity. • MDA, H2O2, and GSH; confirmed the scavenging property of the derived biosurfactant through ROS. • Synthesized formula encourages the healing of the wound because of its antioxidant capacity.


Subject(s)
Acinetobacter , Antioxidants/pharmacology , Surface-Active Agents/pharmacology , Wound Healing/drug effects , Animals , Antioxidants/therapeutic use , Glutathione/metabolism , Humans , Male , Malondialdehyde/metabolism , Mice , Rats, Wistar , Reactive Oxygen Species/metabolism , Surface-Active Agents/therapeutic use
18.
Avicenna J Med Biotechnol ; 5(2): 118-24, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23799180

ABSTRACT

BACKGROUND: Shigellosis is a leading cause of diarrhea in many developing countries and although the disease can be controlled and managed with antibiotics, the constant emergence of resistant species requiring ever newer antibacterial drugs make development of an effective vaccine necessary. The bacteria are highly contagious and since immunity to Shigella is serotype-specific a multi-serotype vaccine is required for adequate protection. Proteins encoded by Shigella invasion plasmid, which are part of the Type Three Secretion System (TTSS) of this bacteria, are good candidate as vaccine targets since they are both immunogenic and conserved between different Shigella species. The advent of molecular farming, which is a low cost system, has opened up new venues for production of recombinant proteins. In view of the difficulties encountered in expressing IpaB in Escherichia coli (E. coli), the feasibility of the expression of this protein in tobacco has been investigated. METHODS: The ipaB gene was cloned in place of the Hygromycin gene in pCambia1304 containing GFP as a reporter gene. The vector was then transferred into competent Agrobacterium tumefaciens (A. tumefaciens) strain LBA4404 which was used for agro-infiltration of Nicotiana tobaccum (N. tobaccum) leaves. Transformation was confirmed by expression of GFP. The gene was also cloned in pBAD/geneIII A and transformed E. coli host containing the construct was induced using different amounts of L-arabinose as inducer. Expression of IpaB gene by both hosts was determined by Western blotting using anti-IpaB monoclonal antibody. RESULTS: The data obtained showed that IpaB was expressed in plant leaves but expression in E. coli was not detectable. CONCLUSION: This study showed that N. tobaccum is capable of expressing this protein without its specific chaperon and in levels detectable by Western blotting.

SELECTION OF CITATIONS
SEARCH DETAIL
...